ACELYRIN, INC.

EDGAR

Market value is not computed: no recent price is available.

30 filing records in this dataset, filed from 2023-04-13 to 2025-05-14. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Cash and cash equivalents
58.3 million USD Source
Exact value

58271000 USD

Long-term debt including current maturities
Not available
Shares outstanding
101 million shares Source
Exact value

100907206 shares

Reported share-count change

2.07% · 2.05 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 98859000 shares · 2024-03-31· Source
  • 100907206 shares · 2025-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-269 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence
  • Net income: -85672000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -48548000 USD · 2024-07-01 – 2024-09-30 Source
  • Net income: -248226000 USD · 2024-01-01 – 2024-12-31 Source
  • Net income: -169193000 USD · 2024-01-01 – 2024-09-30 Source
  • Net income: -55264000 USD · 2025-01-01 – 2025-03-31 Source

Capital expenditure

1.19 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence
  • Capital expenditure: 869000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 55000 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 1166000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 869000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 1247000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 1166000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 1000 USD · 2025-01-01 – 2025-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-14.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 4 of 11 periods available· newest 2024-12-31
  • Net income: 4 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 4 of 11 periods available· newest 2024-12-31
  • Capital expenditure: 4 of 11 periods available· newest 2024-12-31
  • Total assets: 3 of 11 periods available· newest 2024-12-31
  • Total liabilities: 3 of 11 periods available· newest 2024-12-31
  • Current assets: 3 of 11 periods available· newest 2024-12-31
  • Current liabilities: 3 of 11 periods available· newest 2024-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2024-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 133.42 million

    Prior period

    −USD 381.64 million

    –

    Current period

    −USD 248.23 million

    –

    Exact inputs and evidence

    -248226000 − -381641000 = 133415000 USD

    -381641000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -248226000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 134.2 million

    Prior period

    −USD 169.7 million

    –

    Current period

    −USD 303.9 million

    –

    Exact inputs and evidence

    -303900000 − -169700000 = -134200000 USD

    -169700000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -303900000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -45.6%

    Prior period

    USD 2.29 million

    –

    Current period

    USD 1.25 million

    –

    Exact inputs and evidence

    1247000 − 2294000 = -1047000 USD

    2294000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    1247000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−USD 41.84 million
Exact value

Exact value: -41839000 USD

2021-01-01 – 2021-12-31: -41839000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5 million
Exact value

Exact value: -5000000 USD

2021-01-01 – 2021-12-31: -5000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5 million
Calculation and evidence

-5000000 − 0 USD

Exact free cash flow: -5000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 64.77 million
Exact value

Exact value: -64772000 USD

2022-01-01 – 2022-12-31: -64772000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 61.5 million
Exact value

Exact value: -61500000 USD

2022-01-01 – 2022-12-31: -61500000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2022-01-01 – 2022-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 61.5 million
Calculation and evidence

-61500000 − 0 USD

Exact free cash flow: -61500000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 381.64 million
Exact value

Exact value: -381641000 USD

2023-01-01 – 2023-12-31: -381641000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 169.7 million
Exact value

Exact value: -169700000 USD

2023-01-01 – 2023-12-31: -169700000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.29 million
Exact value

Exact value: 2294000 USD

2023-01-01 – 2023-12-31: 2294000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 171.99 million
Calculation and evidence

-169700000 − 2294000 USD

Exact free cash flow: -171994000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 248.23 million
Exact value

Exact value: -248226000 USD

2024-01-01 – 2024-12-31: -248226000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 303.9 million
Exact value

Exact value: -303900000 USD

2024-01-01 – 2024-12-31: -303900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.25 million
Exact value

Exact value: 1247000 USD

2024-01-01 – 2024-12-31: 1247000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 305.15 million
Calculation and evidence

-303900000 − 1247000 USD

Exact free cash flow: -305147000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 593 latest values · 593 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001962918, 1962918, SLRN, edgar:1962918

Also known as ACELYRIN, INC., ACELYRIN, Inc.